open access

Vol 73, No 1 (2022)
Review paper
Submitted: 2021-08-05
Accepted: 2021-11-25
Published online: 2022-02-02
Get Citation

The COVID-19 lockdown does not necessarily worsen diabetes control, in spite of lower physical activity — a systematic review

Abdulrhman Aldukhayel1
·
Pubmed: 35119094
·
Endokrynol Pol 2022;73(1):131-148.
Affiliations
  1. Department of Family and Community Medicine, College of Medicine, Qassim University, Buraydah, Saudi Arabia

open access

Vol 73, No 1 (2022)
Review Article
Submitted: 2021-08-05
Accepted: 2021-11-25
Published online: 2022-02-02

Abstract

Introduction: This review aimed to synthesize evidence on the impact of the COVID-19 lockdown on the glycaemic control, physical activity, and diet of diabetic patients.

Material and methods: Two electronic databases (PubMed and Scopus) were searched from January 2020 to February 2021. A total of 161 unique records were retrieved. Out of these, 25 articles met the eligibility criteria and were included in the final review. The quality of the studies was assessed by using the modified Newcastle-Ottawa Quality Assessment Scale for observational studies.  

Results: Out of the 25 studies included in the review, 18 (72%) were cross sectional, 5 (20%) were retrospective analyses, and 2 (8%) were cohort studies. Thirteen studies included type I diabetics, 8 studies included type 2 diabetics, and 4 studies included both. In the quality assessment, 17 (68%) of the studies met the criteria of satisfactory quality. Overall glycaemic parameters were improved during the lockdown. Dietary patterns were affected during the lockdown, but the direction of change — either negative or positive — could not be inferred. However, physical activity patterns were found to be deteriorated during the lockdown.

Conclusion: The review found that lockdowns for curbing COVID-19 had no negative impact on glucose control, while there was a decline in the physical activity among diabetics.  Furthermore, available studies are subject to various biases, which calls for robust studies in future with representative samples. There is also a need to promote physical activity and a healthy diet among diabetic patients, with follow-up through telemedicine during such confinement periods.

Abstract

Introduction: This review aimed to synthesize evidence on the impact of the COVID-19 lockdown on the glycaemic control, physical activity, and diet of diabetic patients.

Material and methods: Two electronic databases (PubMed and Scopus) were searched from January 2020 to February 2021. A total of 161 unique records were retrieved. Out of these, 25 articles met the eligibility criteria and were included in the final review. The quality of the studies was assessed by using the modified Newcastle-Ottawa Quality Assessment Scale for observational studies.  

Results: Out of the 25 studies included in the review, 18 (72%) were cross sectional, 5 (20%) were retrospective analyses, and 2 (8%) were cohort studies. Thirteen studies included type I diabetics, 8 studies included type 2 diabetics, and 4 studies included both. In the quality assessment, 17 (68%) of the studies met the criteria of satisfactory quality. Overall glycaemic parameters were improved during the lockdown. Dietary patterns were affected during the lockdown, but the direction of change — either negative or positive — could not be inferred. However, physical activity patterns were found to be deteriorated during the lockdown.

Conclusion: The review found that lockdowns for curbing COVID-19 had no negative impact on glucose control, while there was a decline in the physical activity among diabetics.  Furthermore, available studies are subject to various biases, which calls for robust studies in future with representative samples. There is also a need to promote physical activity and a healthy diet among diabetic patients, with follow-up through telemedicine during such confinement periods.

Get Citation

Keywords

COVID-19; diabetes; physical activity; diet; glycaemia; control

Supp./Additional Files (1)
Untitled
Download
96KB
About this article
Title

The COVID-19 lockdown does not necessarily worsen diabetes control, in spite of lower physical activity — a systematic review

Journal

Endokrynologia Polska

Issue

Vol 73, No 1 (2022)

Article type

Review paper

Pages

131-148

Published online

2022-02-02

Page views

6198

Article views/downloads

629

DOI

10.5603/EP.a2022.0006

Pubmed

35119094

Bibliographic record

Endokrynol Pol 2022;73(1):131-148.

Keywords

COVID-19
diabetes
physical activity
diet
glycaemia
control

Authors

Abdulrhman Aldukhayel

References (43)
  1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2021. https://covid19.who.int/table.
  2. Güner R, Hasanoğlu I, Aktaş F. COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020; 50(SI-1): 571–577.
  3. Ahmed SA, Ajisola M, Azeem K, et al. Improving Health in Slums Collaborative. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ Glob Health. 2020; 5(8).
  4. Witteveen D, Velthorst E. Economic hardship and mental health complaints during COVID-19. Proc Natl Acad Sci U S A. 2020; 117(44): 27277–27284.
  5. Barach P, Fisher SD, Adams MJ, et al. Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks? Prog Pediatr Cardiol. 2020; 59: 101254.
  6. World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases 2020 [cited April 07, 2021. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.
  7. Saeedi P, Salpea P, Karuranga S, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157: 107843.
  8. Gujral UP, Johnson L, Nielsen J, et al. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Res Care. 2020; 8(1).
  9. Peterson J, Welch V, Losos M. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa 2011.
  10. Aragona M, Rodia C, Bertolotto A, et al. Type 1 diabetes and COVID-19: The "lockdown effect". Diabetes Res Clin Pract. 2020; 170: 108468.
  11. Longo M, Caruso P, Petrizzo M, et al. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy. Diabetes Res Clin Pract. 2020; 169: 108440.
  12. Mesa A, Viñals C, Pueyo I, et al. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020; 167: 108354.
  13. Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020; 14(6): 1963–1966.
  14. Pla B, Arranz A, Knott C, et al. Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus. J Endocr Soc. 2020; 4(12): bvaa149.
  15. Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020 [Epub ahead of print]: 1–6.
  16. Ruissen MM, Regeer H, Landstra CP, et al. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021; 9(1).
  17. Anjana RM, Pradeepa R, Deepa M, et al. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Diabetes Technol Ther. 2020; 22(7): 527–534.
  18. Olickal JJ, Chinnakali P, Suryanarayana BS, et al. Effect of COVID19 pandemic and national lockdown on persons with diabetes from rural areas availing care in a tertiary care center, southern India. Diabetes Metab Syndr. 2020; 14(6): 1967–1972.
  19. Alshareef R, Al Zahrani A, Alzahrani A, et al. Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia. Diabetes Metab Syndr. 2020; 14(5): 1583–1587.
  20. Capaldo B, Annuzzi G, Creanza A, et al. Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes. Diabetes Care. 2020; 43(8): e88–e89.
  21. Cotovad-Bellas L, Tejera-Pérez C, Prieto-Tenreiro A, et al. The challenge of diabetes home control in COVID-19 times: Proof is in the pudding. Diabetes Res Clin Pract. 2020; 168: 108379.
  22. Ghosh A, Arora B, Gupta R, et al. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14(5): 917–920.
  23. Khare J, Jindal S, Khare J, et al. Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India. Diabetes Metab Syndr. 2020; 14(6): 1571–1574.
  24. Khare J, Jindal S. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India. Prim Care Diabetes. 2021 [Epub ahead of print].
  25. Magliah SF, Zarif HA, Althubaiti A, et al. Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown. Diabetes Metab Syndr. 2021; 15(1): 63–68.
  26. Assaloni R, Pellino VC, Puci MV, et al. Coronavirus disease (Covid-19): How does the exercise practice in active people with type 1 diabetes change? A preliminary survey. Diabetes Res Clin Pract. 2020; 166: 108297.
  27. Barchetta I, Cimini FA, Bertoccini L, et al. Effects of work status changes and perceived stress onglycaemiccontrol in individuals with type 1 diabetes during COVID-19 lockdown in Italy. Diabetes Res Clin Pract. 2020; 170: 108513.
  28. Barone MT, Harnik SB, de Luca PV, et al. The impact of COVID-19 on people with diabetes in Brazil. Diabetes Res Clin Pract. 2020; 166: 108304.
  29. Khader MA, Jabeen T, Namoju R. A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India. Diabetes Metab Syndr. 2020; 14(6): 1579–1584.
  30. Bonora BM, Boscari F, Avogaro A, et al. Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther. 2020 [Epub ahead of print]: 1–11.
  31. Di Dalmazi G, Maltoni G, Bongiorno C, et al. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care. 2020; 8(2).
  32. Dover AR, Ritchie SA, McKnight JA, et al. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabet Med. 2021; 38(1): e14374.
  33. Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020; 166: 108348.
  34. Sankar P, Ahmed WN, Mariam Koshy V, et al. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. Diabetes Metab Syndr. 2020; 14(6): 1815–1819.
  35. Goeijenbier M, van Sloten TT, Slobbe L, et al. Benefits of flu vaccination for persons with diabetes mellitus: A review. Vaccine. 2017; 35(38): 5095–5101.
  36. Wu H, Lau ESH, Ma RCW, et al. Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia. 2020; 63(4): 757–766.
  37. Bloomgarden ZT. Diabetes and COVID-19. J Diabetes. 2020; 12(4): 347–348.
  38. Shin L, Bowling FL, Armstrong DG, et al. Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities. Diabetes Care. 2020; 43(8): 1704–1709.
  39. Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr. 2020; 14(4): 273–276.
  40. Ammar A, Brach M, Trabelsi K, et al. Effects of COVID-19 home confinement on physical activity and eating behaviour Preliminary results of the ECLB-COVID19 international online-survey. Nutrients. 2020; 12(6): 1583.
  41. Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, et al. Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. Nutrients. 2020; 12(6).
  42. Ekelund U, Steene-Johannessen J, Brown WJ, et al. Lancet Physical Activity Series 2 Executive Committe, Lancet Sedentary Behaviour Working Group. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016; 388(10051): 1302–1310.
  43. Marçal IR, Fernandes B, Viana AA, et al. The Urgent Need for Recommending Physical Activity for the Management of Diabetes During and Beyond COVID-19 Outbreak. Front Endocrinol (Lausanne). 2020; 11: 584642.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl